Tolonium chloride 1% topical solution
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Suspected adverse reactions reported for Tolonium chloride
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 6 studies.
Reviews & meta-analyses: 1 · 1983–2024
Showing all 6 studies, sorted by most relevant.
D. Rosenberg, S. Cretin
Oral surgery, oral medicine, and oral pathology, 1989
- Tolonium Chloride
- Meta-Analysis as Topic
- Mass Screening
A. Mashberg
Journal of the American Dental Association, 1983
- Mouthwashes
- Tolonium Chloride
- Carcinoma, Squamous Cell
Afsaneh Ghahari, Farzaneh Farzad, Reza Azadnejad
npj Clean Water, 2024
Abstract The development of effective solid adsorbents is necessary to remove organic pollutants from wastewater in response to the global water crisis. The present study investigates the adsorption behavior of dye pollutants on a 1, 3, 6, 8-tetrakis (4formylphenyl) pyrene (TFPPy) for the self-assembly of an innovative three-dimensional (3D) covalent organic frameworks (COFs). Molecular dynamics (MD) and the well-tempered metadynamics simulation were used to evaluate the ability of COFs to adsorb seven types of dye pollutants (DPs). These include methyl orange (MO), gentian violet (GV), brilliant green (BG), tolonium chloride (TC), methylene blue (MB), anionic congo red (CR), and rhodamine B (Rh B). To examine this process, several descriptors are calculated from the simulation trajectories, including interaction energies, root-mean-square deviation, radial distribution function, solvent-accessible surface area, mean square displacement, and the number of hydrogen bonds to figure out the process. After analyzing the data, it was found that the MO/COFs system displayed exceptional stability. It was confirmed by a significant value of −448.54 KJmol −1 for total interaction energy. The density profile of dye molecules in the MO and Rh B-COFs systems exhibits the highest peaks at approximately 325.79, and 26.75 kg/m³, respectively. The free energy values for the DPs/COFs complexes at their global minima reached about, −512.127, −435.603, −381.244, −300.313, and −283.230 kJmol -1 for MO/GV/BG/TC/ and Rh B with the COFs, respectively. The nature of the design of TFFPy-COF’s unique, ultrafast kinetics, high adsorption capacity, and good reusability endow them with great potential for removing dyes in an aqueous environment.
Abstract licence: CC BY
J. Epstein, R. Feldman, R. Dolor, et al.
Head & Neck, 2003
- Coloring Agents
- Tolonium Chloride
- Head and Neck Neoplasms
Marwan El Mobadder, Samir Nammour, Kinga Grzech-Leśniak
Journal of Clinical Medicine, 2023
This study aimed to evaluate the efficacy of photodynamic therapy (PDT) using tolonium chloride and a 635 nm diode laser as an adjunct to non-surgical periodontitis treatment, specifically scaling and root planing (SRP) alone. A total of 32 patients with a pocket probing depth > 5 mm were included in the study. Among them, 16 patients underwent SRP alone (control group), and the remaining 16 patients received SRP along with PDT (study group). The PDT procedure utilized a 635 nm diode laser (Smart M, Lasotronix, Poland) and tolonium chloride. Clinical periodontal parameters, such as the plaque index (PI), bleeding on probing (BOP), gingival recession (GR), probing pocket depth (PPD), and clinical attachment loss (CAL), were assessed before treatment (T0) and at 3 months after treatment (T3). At T3, both groups demonstrated a significant reduction in the PI, BOP, PD, and CAL compared to T0. The SRP + PDT group displayed a significant reduction in PPD (3.79 mm ± 0.35) compared to the SRP alone group (4.85 mm ± 0.42) at T3. Furthermore, the SRP + PDT group exhibited a significant reduction in CAL (5.01 ± 0.81) compared to the SRP group (5.99 ± 1.08) at T3. Within the study's limitations, it was concluded that PDT, with tolonium chloride and a 635 nm diode laser, significantly contributed to the non-surgical treatment of periodontitis.
Abstract licence: CC BY
Patricia Umoru, Mohammad Lawal, Oluwayemisi Abiodun Babatunde, et al.
Journal of the Turkish Chemical Society Section A: Chemistry, 2024
The degradation of tolonium chloride (TC+) dye by phosphate ion (PO43-) in an aqueous acidic solution was studied using spectrophotometric analysis at 301 K, I= 1.0 M, [TC+]= 1.5 × 10-5 M, [H+]= 1.0×10-3 M, and ʎmax 600 nm. To determine the potency and rate of the reactant species, an aqueous acidic medium was employed. The reaction's direction and tendency were predicted using a thermodynamic analysis at an interval of 5.0 K and a temperature range of 301-321 K. Without the presence of intermediate complex/free atoms formation, a reaction that produced phenyl sulphoxide, phenylamine, and HPO32- as products of the reaction was obtained with a molar ratio of 1:1 for both reactants. First-order tolonium chloride reactivity was found in the reaction and first-order for the phosphate ion, resulting in a second-order reaction overall. The reaction process accelerated as the concentration of hydrochloric acid rose. The response time decreased with an increase in ionic strength concentration and added Ca2+ and Cl- did catalyze the reaction positively. A straight line that went through the origin was produced by plotting 1/ko vs PO43- concentration. The spectroscopic analysis showed no discernible shift from λmax of 600 nm. Additionally, an increase in temperature accelerated the reaction process. The reaction has a negative free energy change, G (-3.13–1.12 KJ/mol) which indicates that it is spontaneous and that the reactants have more free energy than that of the products. While the enthalpy of activation, H is positive and indicates that the reaction was endothermic and followed an associative path, the entropy of activation, S, is also negative (-7.45–1.10 KJ/mol), indicating that the reaction is less disordered. Due to the added ions catalysis and absence of free atoms during the course of the reaction, an outer-sphere mechanism was suggested for the reaction.
Abstract licence: CC BY-NC-ND
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.